from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1166/lpqW

LFCtreatmentdescriptionclass of inhibitor

-0.842

Amikacinug/mL Amikacintranslation

-2.410

Cap5-10ug/mL Capreomycintranslation

-0.905

Rox10-50 ug/mL Roxithromycintranslation

-0.204

SM2-5 ug/mL Streptomycintranslation

-1.054

Tet5-10 ug/mL Tetracyclinetranslation

0.268

Rif0.2-5ug/mL Rifampicintranscription

0.570

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.621

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.133

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.495

CPZ10-50 ug/mL Chlorpromazinerespiration

0.125

Clofazimine10-13 ug/mL Clofaziminerespiration

0.521

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.643

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.853

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.174

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.911

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.184

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.469

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.504

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.183

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.096

KCN5-20 ug/mL Potassium cyaniderespiration

0.349

NaN30.2-2 mM Sodium aziderespiration

-0.186

Nigericin50 uM Nigericinrespiration

-0.740

TRC10-150 ug/mL Triclosanrespiration

-1.296

TRZ10-25 ug/mL Thioridazinerespiration

-1.710

Valinomycin0.5-10 uM Valinomycinrespiration

-0.144

ZnSO42 mM ZnSO4respiration

-1.103

menadione6-10 ug/mL Menadionerespiration

0.097

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.480

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.179

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.134

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.812

NRP_1Non-replicating persistence stage 1dosRassociated

0.015

Amp0.2mg/mL AmpicillincellWall

0.421

Cephalexin20-100 ug/mL CephalexincellWall

0.384

Cerulenin0.32-5 ug/mL CerulenincellWall

0.338

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.129

EMB10-20 ug/mL EthambutolcellWall

-0.356

Eta12-40 ug/mL EthionamidecellWall

-0.271

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.325

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.818

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.979

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.877

BZA0.12 mg/mL BenzamidearomaticAmides

0.151

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.587

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.315

H2O24 mM hydrogen peroxideDNAdamaging

-0.079

Levo10 ug/mL LevofloxacinDNAdamaging

0.507

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.461

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.646

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.120

UVUV-irradiationDNAdamaging

-0.707

ARP41-4 ug/mL Antitubercular compound ARP4?

0.066

Antimycin12.5-50 ug/mL Antimycin A?

0.298

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.312

PA_110-50 ug/mL Antitubercular compound PA-1?

0.383

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.113

PA8240.2-2 ug/mL PA-824?

0.150

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.551

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.340

Verapamil50 uM Verapamil?

-0.113

mercaptoethanol2 mM 2-Mercaptoethanol?

1.061

methoxatin10-20 ug/mL Methoxatin?